Concepedia

Publication | Open Access

Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia

DOIFull Paper Access

553

Citations

28

References

1997

Year

François Guilhot, Claude Chastang, Mauricette Michallet, Agnès Guerci, Jean‐Luc Harousseau, Frédéric Maloisel, Réda Bouabdallah, Denis Guyotat, Nathalie Cheron, Franck E. Nicolini,
New England Journal of Medicine

Abstract

The combination of interferon and cytarabine, as compared with interferon alone, increases the rate of major cytogenetic response and prolongs survival in patients with the chronic phase of chronic myelogenous leukemia.

References

YearCitations

Page 1